Software applications residing on handheld analyte determining devices

US12112854B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12112854-B2
Application numberUS-201815901791-A
CountryUS
Kind codeB2
Filing dateFeb 21, 2018
Priority dateFeb 11, 2011
Publication dateOct 8, 2024
Grant dateOct 8, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.

First claim

Opening claim text (preview).

What is claimed is: 1. An analyte monitoring system, comprising: an analyte measurement device configured to receive data indicative of an analyte level from an in vivo sensor, the analyte measurement device comprising a processor and a computer-readable storage medium having a software application stored thereon, wherein the software application includes a tagging mode, and wherein the software application, when executed, causes the processor to: in response to an analyte measurement result being outside of a target analyte range for a user, automatically display the analyte measurement result, wherein the target analyte range comprises a lower limit and an upper limit, and wherein the analyte measurement result is based on the data indicative of the analyte level; and automatically display a tagging input interface in real time in response to (1) the tagging mode being enabled and (2) the analyte measurement result being outside of the target analyte range for the user, wherein the tagging input interface is configured to prompt the user to tag the analyte measurement result, wherein the tagging mode is enabled according to a predetermined schedule comprising predefined time periods, wherein the tagging input interface is not displayed if the analyte measurement result is within the target range, wherein the analyte measurement result is displayed in response to the analyte measurement result being outside of the target analyte range without displaying the tagging input interface when the tagging mode is disabled. 2. The analyte monitoring system of claim 1 , wherein the software application, when executed, causes the processing device to automatically cause display of the tagging input interface that requests the user tag the analyte measurement result with a tag selected from the group comprising: fasting, pre-meal, or post-meal. 3. The analyte monitoring system of claim 1 , wherein the software application, when executed, causes the processing device to automatically cause display of the tagging input interface that requests the user tag the analyte measurement result with a tag selected from the group comprising: a meal or a fasting period. 4. The analyte monitoring system of claim 1 , wherein the software application, when executed, causes the processing device to automatically cause display of the tagging input interface that requests the user tag the analyte measurement result with a tag selected from the group comprising: a drug administration, a drug amount, or a meal amount. 5. The analyte monitoring system of claim 1 , wherein the software application, when executed, causes the processing device to record the tag as a time-stamped event. 6. The analyte monitoring system of claim 1 , wherein the software application, when executed, causes the processing device to cause display of a reminder for the user to enter information, wherein the information is selected from the group comprising: a time of a meal, an amount of a meal, a time of a bolus, or an amount of a bolus. 7. The analyte monitoring system of claim 6 , wherein the software application, when executed, causes the processing device to cause display of the reminder during each of a plurality of predefined time periods. 8. The analyte monitoring system of claim 7 , wherein the plurality of predefined time periods comprise a morning time period, a mid-day time period, and an evening time period. 9. The analyte monitoring system of claim 7 , wherein the information is associated with each of the plurality of predefined time periods, and wherein the software application, when executed, causes the processing device to cause display of the reminder during each of a plurality of predefined time periods only if the information associated with that predefined time period has not been entered. 10. The analyte monitoring system of claim 1 , wherein the analyte measurement result is a glucose measurement result. 11. The analyte monitoring system of claim 1 , wherein the software application, when executed, causes the processing device to determine whether the analyte measurement result is outside the target analyte range for the user. 12. The analyte monitoring system of claim 11 , wherein the tagging input interface is automatically caused to be displayed only if the analyte measurement result is determined to be outside of the target analyte range for the user and only if the at least one processing device is operating in a first mode, wherein the software application, when executed, causes the processing device to automatically operate in the first mode based on a health care professional office visit reminder.

Assignees

Inventors

Classifications

  • ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance · CPC title

  • for measuring glucose, e.g. by tissue impedance measurement · CPC title

  • for remote operation · CPC title

  • ICT specially adapted for medical reports, e.g. generation or transmission thereof · CPC title

  • for computer-aided diagnosis, e.g. based on medical expert systems · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12112854B2 cover?
Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification G16H80/00. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).